Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study-Reference-Cited by-同舟云学术

Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study

Published:2007-06 Issue:6 Volume:8 Page:500-512
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Gridelli Cesare,Gallo Ciro,Ceribelli Anna,Gebbia Vittorio,Gamucci Teresa,Ciardiello Fortunato,Carozza Francesco,Favaretto Adolfo,Daniele Bruno,Galetta Domenico,Barbera Santi,Rosetti Francesco,Rossi Antonio,Maione Paolo,Cognetti Francesco,Testa Antonio,Di Maio Massimo,Morabito Alessandro,Perrone Francesco

Publisher

Elsevier BV

Subject

Oncology

Reference43 articles.

1. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials;BMJ,1995

2. Treatment of non-small-cell lung cancer: state of the art and development of new biologic agents;Gridelli;Oncogene,2003

3. Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a meta-analysis of the published literature;D'Addario;J Clin Oncol,2005

4. Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: a Southwest Oncology Group trial;Kelly;J Clin Oncol,2001

5. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer;Schiller;N Engl J Med,2002

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring synthetic xanthone derivatives as potential anti-inflammatory agents: a comprehensive review;Chemical Papers;2024-08

2. Association of ankylosing spondylitis with the risk of cancer: a meta-analysis of cohort studies;Rheumatology;2024-06-03

3. Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials;ESMO Open;2024-03

4. Cardiovascular/anti‐inflammatory drugs repurposed for treating or preventing cancer: A systematic review and meta‐analysis of randomized trials;Cancer Medicine;2024-03

5. A Systematic Review of Literatures: To Identify Non-Cancer Drugs Repurposed for Lung Cancer;2023-12-04